Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Ferrand

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2005
Intrathymic administration of hematopoietic progenitor cells enhances T cell reconstitution in ZAP-70 severe combined immunodeficiencyOumeya Adjali, Rita R Vicente, Christophe Ferrand, et al.
Current Research in Translational Medicine|June 6, 2019
Altered thymic CD4<sup>+</sup> T-cell recovery after allogeneic hematopoietic stem cell transplantation is critical for nocardiosisXavier Roussel, Etienne Daguindau, Ana Berceanu, et al.
Arthritis and Rheumatism|May 28, 2010
CD3+CD20+ cells may be an artifact of flow cytometry: comment on the article by Wilk et alCarole Henry, Abdulraouf Ramadan, Nicolas Montcuquet, et al.
Journal of the American Society of Nephrology : JASN|July 14, 2006
IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantationJamal Bamoulid, Cécile Courivaud, Marina Deschamps, et al.
Immunology|May 1, 2008
Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cellsNicolas Montcuquet, Patricia Mercier-Letondal, Sylvain Perruche, et al.
The Journal of Clinical Investigation|September 23, 2009
Evidence of premature immune aging in patients thymectomized during early childhoodDelphine Sauce, Martin Larsen, Solène Fastenackels, et al.
BMC Cancer|April 4, 2013
Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumorsNicolas Isambert, Pierre Fumoleau, Catherine Paul, et al.
Cancer Gene Therapy|January 8, 2021
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switchWalid Warda, Mathieu Neto Da Rocha, Rim Trad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemiaMark Bonyhadi, Mark Frohlich, Angela Rasmussen, et al.
Transplant Immunology|May 31, 2011
Thymic function, anti-thymocytes globulins, and cancer after renal transplantationDidier Ducloux, Jamal Bamoulid, Cécile Courivaud, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2005
Intrathymic administration of hematopoietic progenitor cells enhances T cell reconstitution in ZAP-70 severe combined immunodeficiencyOumeya Adjali, Rita R Vicente, Christophe Ferrand, et al.
Current Research in Translational Medicine|June 6, 2019
Altered thymic CD4<sup>+</sup> T-cell recovery after allogeneic hematopoietic stem cell transplantation is critical for nocardiosisXavier Roussel, Etienne Daguindau, Ana Berceanu, et al.
Arthritis and Rheumatism|May 28, 2010
CD3+CD20+ cells may be an artifact of flow cytometry: comment on the article by Wilk et alCarole Henry, Abdulraouf Ramadan, Nicolas Montcuquet, et al.
Journal of the American Society of Nephrology : JASN|July 14, 2006
IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantationJamal Bamoulid, Cécile Courivaud, Marina Deschamps, et al.
Immunology|May 1, 2008
Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cellsNicolas Montcuquet, Patricia Mercier-Letondal, Sylvain Perruche, et al.
The Journal of Clinical Investigation|September 23, 2009
Evidence of premature immune aging in patients thymectomized during early childhoodDelphine Sauce, Martin Larsen, Solène Fastenackels, et al.
BMC Cancer|April 4, 2013
Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumorsNicolas Isambert, Pierre Fumoleau, Catherine Paul, et al.
Cancer Gene Therapy|January 8, 2021
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switchWalid Warda, Mathieu Neto Da Rocha, Rim Trad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemiaMark Bonyhadi, Mark Frohlich, Angela Rasmussen, et al.
Transplant Immunology|May 31, 2011
Thymic function, anti-thymocytes globulins, and cancer after renal transplantationDidier Ducloux, Jamal Bamoulid, Cécile Courivaud, et al.
Pageof 11